BICTEGRAVIR + EMTRICITABINE + TENOFOVIR ALAFENAMIDE
bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet, 30
BICTEGRAVIR + EMTRICITABINE + TENOFOVIR ALAFENAMIDE (11649D)
11649D
Manner of administration:Oral
Restriction 4522
Indication: HIV infection
Treatment phase: Initial
Restriction 4470
Indication: HIV infection
Treatment phase: Continuing
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $1,759.52 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Biktarvy | |||||